July 11, 2014 9:49 AM ET

Pharmaceuticals

Company Overview of Speedel Holding AG

Company Overview

Speedel Holding AG was acquired by Novartis AG. Speedel Holding AG, a biopharmaceutical company, develops renin inhibitors for treatment of cardiovascular and metabolic diseases. The company’s products include SPP100, which is used for the treatment of hypertension, and in Phase III clinical trial for the treatment of diabetic nephropathy; SPP200, a Phase II completed clinical trial product for the treatment of graft occlusion in chronic hemodialysis; and SPP301, a Phase II completed clinical trial product for diabetic nephropathy. Its products also comprise SPP635, a Phase IIa clinical trial product for hypertension and end organ protection; SPP676, a Phase I clinical trial product for hype...

Forum 1

Novartis Campus

Basel,  4056

Switzerland

Founded in 1998

84 Employees

Phone:

41 61 324 11 11

Fax:

41 61 324 80 01

Key Executives for Speedel Holding AG

Speedel Holding AG does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Actelion Pharmaceuticals Ltd Europe
Aspreva Pharmaceuticals SA Europe
Novartis Vaccines and Diagnostics Services AG Europe
Janssen-Cilag AG Europe
Devirex AG Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Speedel Holding AG, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.